Skip to main content
Top
Published in: Cellular Oncology 4/2014

01-08-2014 | Original Paper

MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area

Authors: Adfar Yousuf, Mohammad Younis Bhat, Arshad A. Pandith, Dil Afroze, Nighat P. Khan, Khursheed Alam, Parveen Shah, M. Amin Shah, Syed Mudassar

Published in: Cellular Oncology | Issue 4/2014

Login to get access

Abstract

Purpose

Inactivation of tumor suppressor and DNA repair genes by promoter hypermethylation does commonly occur in human cancers. O6-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that removes methyl groups as well as larger adducts at the O6 position of guanine. In the absence of MGMT activity, O6-methylguanine mispairs with thymine during DNA replication, resulting in G:C to A:T transitions. Promoter hypermethylation of the MGMT gene has been observed in various cancers, including gastric cancer. Here, we aimed at assessing the promoter hypermethylation, mutation and expression status of the MGMT gene in patients from a geographic region with a high incidence of gastric cancer (Kashmir, North India) and to investigate their association with various clinicopathological characteristics.

Methods

In this study 82 gastric cancer samples and adjacent normal tissues were included. Mutations in the MGMT gene were detected by single stranded conformational polymorphism (SSCP) analysis and direct sequencing. Methylation-specific polymerase chain reaction (MS-PCR) and Western blot analyses were performed to detect promoter hypermethylation and concomitant (loss of) expression of the MGMT gene.

Results

Promoter hypermethylation of the MGMT gene was found in 52.44 % (43 of 82) of the tumor samples and loss of MGMT protein expression was detected in 45.12 % (37 of 82) of the tumor samples. Hypermethylation and loss of expression were significantly associated with higher tumor grades (moderately/poorly differentiated) (P < 0.05) and higher tumor stages (III/IV) (P < 0.05). In addition, MGMT hypermethylation and loss of expression were found to be significantly associated with high salt tea consumption (P < 0.05).

Conclusions

Our results indicate that MGMT promoter hypermethylation and concomitant loss of MGMT protein expression may play an important role in the development of gastric cancer in the Kashmiri population. High salt tea consumption may be a risk factor.
Appendix
Available only for authorised users
Literature
1.
go back to reference A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011)PubMedCrossRef A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011)PubMedCrossRef
2.
4.
go back to reference D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics 2002. CA Cancer J. Clin. 55, 74–108 (2005)PubMedCrossRef D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics 2002. CA Cancer J. Clin. 55, 74–108 (2005)PubMedCrossRef
5.
go back to reference V. Rao, B. Ganesh, Estimate of cancer incidence in India in 1991. Indian J. Cancer 35, 10–18 (1998)PubMed V. Rao, B. Ganesh, Estimate of cancer incidence in India in 1991. Indian J. Cancer 35, 10–18 (1998)PubMed
6.
go back to reference P. Arshad, S. Mushtaq, Burden of cancers in the valley of Kashmir, 5 year epidemiological study reveals a different scenario. Tumor Biol. 33, 1629–1637 (2012)CrossRef P. Arshad, S. Mushtaq, Burden of cancers in the valley of Kashmir, 5 year epidemiological study reveals a different scenario. Tumor Biol. 33, 1629–1637 (2012)CrossRef
7.
go back to reference P. Correa, Human gastric carcinogenesis, a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 52, 6735–6740 (1992)PubMed P. Correa, Human gastric carcinogenesis, a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 52, 6735–6740 (1992)PubMed
8.
go back to reference N. Oue, H. Shigeishi, H. Kuniyasu, H. Yokozaki, K. Kuraoka, R. Ito, W. Yasui, Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int. J. Cancer 93, 805–809 (2001)PubMedCrossRef N. Oue, H. Shigeishi, H. Kuniyasu, H. Yokozaki, K. Kuraoka, R. Ito, W. Yasui, Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int. J. Cancer 93, 805–809 (2001)PubMedCrossRef
9.
go back to reference T.H. Yoo, B.K. Ryu, M.G. Lee, S.G. Chi, CD81 is a candidate tumor suppressor gene in human gastric cancer. Cell. Oncol. 36, 141–153 (2013)CrossRef T.H. Yoo, B.K. Ryu, M.G. Lee, S.G. Chi, CD81 is a candidate tumor suppressor gene in human gastric cancer. Cell. Oncol. 36, 141–153 (2013)CrossRef
10.
go back to reference J. Houghton, T.C. Wang, Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128, 1567–1578 (2005)PubMedCrossRef J. Houghton, T.C. Wang, Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128, 1567–1578 (2005)PubMedCrossRef
11.
go back to reference R. Yan, X. Peng, X. Yuan, D. Huang, J. Chen, Q. Lu, N. Lv, S. Luo, Suppression of growth and migration by blocking the Hedgehog signaling pathway in gastric cancer cells. Cell. Oncol. 36, 421–435 (2013)CrossRef R. Yan, X. Peng, X. Yuan, D. Huang, J. Chen, Q. Lu, N. Lv, S. Luo, Suppression of growth and migration by blocking the Hedgehog signaling pathway in gastric cancer cells. Cell. Oncol. 36, 421–435 (2013)CrossRef
12.
go back to reference M. Labots, T.E. Buffart, J.C. Haan, N.C. Grieken, M. Tijssen, C.J. van de Velde, H.I. Grabsch, B. Ylstra, B. Carvalho, R.J. Fijneman, H.M. Verheul, G.A. Meijer, High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection. Cell. Oncol. 37, 41–52 (2014)CrossRef M. Labots, T.E. Buffart, J.C. Haan, N.C. Grieken, M. Tijssen, C.J. van de Velde, H.I. Grabsch, B. Ylstra, B. Carvalho, R.J. Fijneman, H.M. Verheul, G.A. Meijer, High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection. Cell. Oncol. 37, 41–52 (2014)CrossRef
13.
go back to reference H.A. Diwani, G.M. Malik, N.M. Tikku, M. Khan, The presentation of gastric cancer in Kashmiri native and analysis of 850 cases. JIMA 20, 50–53 (1988) H.A. Diwani, G.M. Malik, N.M. Tikku, M. Khan, The presentation of gastric cancer in Kashmiri native and analysis of 850 cases. JIMA 20, 50–53 (1988)
14.
go back to reference M.S. Khuroo, S.A. Zargar, R. Mahajan, M.A. Banday, High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 33, 11–15 (1992)PubMedCentralPubMedCrossRef M.S. Khuroo, S.A. Zargar, R. Mahajan, M.A. Banday, High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 33, 11–15 (1992)PubMedCentralPubMedCrossRef
15.
go back to reference A.K. Ticiker, M. Siddiqi, R. Preussmann, Occurrence of volatile. N-nitrosoamines in dried chilies. Cancer Lett. 38, 271–273 (1988)CrossRef A.K. Ticiker, M. Siddiqi, R. Preussmann, Occurrence of volatile. N-nitrosoamines in dried chilies. Cancer Lett. 38, 271–273 (1988)CrossRef
16.
go back to reference M. Siddiqi, A.R. Tricker, R. Kumar, Dietary sources of N-nitrosoamines in a high risk area oesophageal cancer, Kashmir, India, in Relevance to human cancer of N-nitroso compounds, tobacco smoke and Myco-toxins, ed. by I.K. O’Neill, J.S. Chen, S.H. Lu, H. Bartsch, vol. 105 (IARC, Lyon, 1990), pp. 235–237 M. Siddiqi, A.R. Tricker, R. Kumar, Dietary sources of N-nitrosoamines in a high risk area oesophageal cancer, Kashmir, India, in Relevance to human cancer of N-nitroso compounds, tobacco smoke and Myco-toxins, ed. by I.K. O’Neill, J.S. Chen, S.H. Lu, H. Bartsch, vol. 105 (IARC, Lyon, 1990), pp. 235–237
17.
go back to reference M. Siddiqi, R. Preussmann, Esophageal cancer in Kashmir an assessment. J. Cancer Res. Clin. Oncol. 115, 111–117 (1989)PubMedCrossRef M. Siddiqi, R. Preussmann, Esophageal cancer in Kashmir an assessment. J. Cancer Res. Clin. Oncol. 115, 111–117 (1989)PubMedCrossRef
18.
go back to reference A.E. Pegg, Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50, 6119–6129 (1990)PubMed A.E. Pegg, Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50, 6119–6129 (1990)PubMed
19.
go back to reference A.E. Pegg, M.E. Dolan, R.C. Moschel, Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog. Nucleic Acid Res. Mol. Biol. 51, 167–223 (1995)PubMedCrossRef A.E. Pegg, M.E. Dolan, R.C. Moschel, Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog. Nucleic Acid Res. Mol. Biol. 51, 167–223 (1995)PubMedCrossRef
20.
go back to reference T.J. Park, S.U. Han, Y.K. Cho, W.K. Paik, Y.B. Kim, I.K. Lim, Methylation of O6-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 92, 2760–2768 (2001)PubMedCrossRef T.J. Park, S.U. Han, Y.K. Cho, W.K. Paik, Y.B. Kim, I.K. Lim, Methylation of O6-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 92, 2760–2768 (2001)PubMedCrossRef
21.
go back to reference M. Esteller, S.R. Hamilton, P.C. Burger, S.B. Baylin, J.G. Herman, Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59, 793–797 (1999)PubMed M. Esteller, S.R. Hamilton, P.C. Burger, S.B. Baylin, J.G. Herman, Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59, 793–797 (1999)PubMed
22.
go back to reference M. Sawhney, N. Rohatgi, J. Kaur, S.D. Gupta, S.V. Deo, N.K. Shukla, R. Ralhan, MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol. 43, 515–522 (2007)PubMedCrossRef M. Sawhney, N. Rohatgi, J. Kaur, S.D. Gupta, S.V. Deo, N.K. Shukla, R. Ralhan, MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol. 43, 515–522 (2007)PubMedCrossRef
23.
go back to reference R.S. Day, C.H. Ziolkowski, D.A. Scudiero, S.A. Meyer, A.S. Lubiniecki, A.J. Girardi, S.M. Galloway, G.D. Bynum, Defective repair of alkylated DNA by human tumor and SV40-transformed human cell strains. Nature 288, 724–727 (1980)PubMedCrossRef R.S. Day, C.H. Ziolkowski, D.A. Scudiero, S.A. Meyer, A.S. Lubiniecki, A.J. Girardi, S.M. Galloway, G.D. Bynum, Defective repair of alkylated DNA by human tumor and SV40-transformed human cell strains. Nature 288, 724–727 (1980)PubMedCrossRef
24.
go back to reference M.F. Paz, M.F. Fraga, S. Avila, M. Guo, M. Pollan, J.G. Herman, M. Esteller, A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63, 1114–1121 (2003)PubMed M.F. Paz, M.F. Fraga, S. Avila, M. Guo, M. Pollan, J.G. Herman, M. Esteller, A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63, 1114–1121 (2003)PubMed
25.
go back to reference L. Wang, D. Zhu, C. Zhang, X. Mao, G. Wang, S. Mitra, B.F. Li, X. Wang, M. Wu, Mutations of O6-methylguanine- DNA methyltransferase gene in esophageal cancer tissues from Northern China. Int. J. Cancer 71, 719–723 (1997)PubMedCrossRef L. Wang, D. Zhu, C. Zhang, X. Mao, G. Wang, S. Mitra, B.F. Li, X. Wang, M. Wu, Mutations of O6-methylguanine- DNA methyltransferase gene in esophageal cancer tissues from Northern China. Int. J. Cancer 71, 719–723 (1997)PubMedCrossRef
26.
go back to reference Y. Liu, Q. Lan, M. Jill, D. James, P. Keohavong, Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia 8, 46–51 (2006)PubMedCentralPubMedCrossRef Y. Liu, Q. Lan, M. Jill, D. James, P. Keohavong, Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia 8, 46–51 (2006)PubMedCentralPubMedCrossRef
27.
go back to reference S. Halford, A. Rowan, E. Sawyer, I. Talbot, I. Tomlinson, O6-methylguanine methyltransferase in colorectal and weak association with G:C > A:T transitions cancers: detection of mutations, loss of expression. Gut 54, 797–802 (2005)PubMedCentralPubMedCrossRef S. Halford, A. Rowan, E. Sawyer, I. Talbot, I. Tomlinson, O6-methylguanine methyltransferase in colorectal and weak association with G:C > A:T transitions cancers: detection of mutations, loss of expression. Gut 54, 797–802 (2005)PubMedCentralPubMedCrossRef
28.
go back to reference W.A. Palmisano, K.K. Divine, G. Saccomanno, F.D. Gilliland, S.B. Baylin, J.G. Herman, S.A. Belinsky, Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60, 5954–5958 (2000)PubMed W.A. Palmisano, K.K. Divine, G. Saccomanno, F.D. Gilliland, S.B. Baylin, J.G. Herman, S.A. Belinsky, Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60, 5954–5958 (2000)PubMed
29.
go back to reference S.L. Rosas, W. Koch, M.G. da Costa Carvalho, L. Wu, J. Califano, W. Westra, J. Jen, D. Sidransky, Promoter hypermethylation patterns of p16, O6-methylguanine DNA methyltransferase, and death associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61, 939–942 (2001)PubMed S.L. Rosas, W. Koch, M.G. da Costa Carvalho, L. Wu, J. Califano, W. Westra, J. Jen, D. Sidransky, Promoter hypermethylation patterns of p16, O6-methylguanine DNA methyltransferase, and death associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61, 939–942 (2001)PubMed
30.
go back to reference K. Virmani, C. Muller, A. Rathi, S. Zoechbauer-Mueller, M. Mathis, A.F. Gazdar, Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 7, 584–589 (2001)PubMed K. Virmani, C. Muller, A. Rathi, S. Zoechbauer-Mueller, M. Mathis, A.F. Gazdar, Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 7, 584–589 (2001)PubMed
31.
go back to reference K.W. Choy, C.P. Pang, K.F. To, C.B. Yu, J.S. Ng, D. SLam, Impaired expression and promoterhypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues. Invest. Ophthalmol. Vis. Sci. 43, 1344–1349 (2002)PubMed K.W. Choy, C.P. Pang, K.F. To, C.B. Yu, J.S. Ng, D. SLam, Impaired expression and promoterhypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues. Invest. Ophthalmol. Vis. Sci. 43, 1344–1349 (2002)PubMed
32.
go back to reference G.H. Kang, J.S. Kim, H.Y. Jung, Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab. Invest. 83, 519–526 (2003)PubMedCrossRef G.H. Kang, J.S. Kim, H.Y. Jung, Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab. Invest. 83, 519–526 (2003)PubMedCrossRef
33.
go back to reference J. Shi, G. Zhang, D. Yao, W. Liu, N. Wang, M. Ji, N. He, B. Shi, P. Hou, Prognostic significance of aberrant gene methylation in gastric cancer. Am. J. Cancer Res. 2, 116–129 (2012)PubMedCentralPubMed J. Shi, G. Zhang, D. Yao, W. Liu, N. Wang, M. Ji, N. He, B. Shi, P. Hou, Prognostic significance of aberrant gene methylation in gastric cancer. Am. J. Cancer Res. 2, 116–129 (2012)PubMedCentralPubMed
34.
go back to reference N. Oue, Y. Oshimo, H. Nakayama, R. Ito, K. Yoshida, K. Matsusaki, W. Yasui, DNA methylation of multiple genes in gastric carcinoma. Association with histological type and CpG island methylator phenotype. Cancer Sci. 94, 901–905 (2003)PubMedCrossRef N. Oue, Y. Oshimo, H. Nakayama, R. Ito, K. Yoshida, K. Matsusaki, W. Yasui, DNA methylation of multiple genes in gastric carcinoma. Association with histological type and CpG island methylator phenotype. Cancer Sci. 94, 901–905 (2003)PubMedCrossRef
35.
go back to reference K. Hibi, M. Sakata, K. Yokomizo, Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma. Anticancer Res. 12, 5053–5055 (2009) K. Hibi, M. Sakata, K. Yokomizo, Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma. Anticancer Res. 12, 5053–5055 (2009)
36.
go back to reference S. Bae, H. Lee, S. Kim, W. Kim, Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Br. J. Cancer 86, 1888–1892 (2002)PubMedCentralPubMedCrossRef S. Bae, H. Lee, S. Kim, W. Kim, Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Br. J. Cancer 86, 1888–1892 (2002)PubMedCentralPubMedCrossRef
37.
go back to reference Z. Xiao-Ping, B. Zhang, X. Zhang, C. Min, C. Jun, L. Wen-Jia, Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum. Pathol. 40, 1534–1542 (2009)CrossRef Z. Xiao-Ping, B. Zhang, X. Zhang, C. Min, C. Jun, L. Wen-Jia, Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum. Pathol. 40, 1534–1542 (2009)CrossRef
38.
go back to reference J. Shen, M.B. Terry, M.D. Gammon et al., MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 26, 2131–2137 (2005)PubMedCrossRef J. Shen, M.B. Terry, M.D. Gammon et al., MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 26, 2131–2137 (2005)PubMedCrossRef
39.
go back to reference L. Shen, Y. Kondo, G. Rosner, L. Xiao, N.S. Hernandez, J. Vilaythong, P. Scott, S. Robert, R. Anil, J.G. Einspahr, B. Julie, D.S. Alberts, R.S. Hamilton, J. Issa, MGMT promoter methylation and field defect in sporadic colorectal cancer. JNCI 97, 1330–1338 (2005)PubMedCrossRef L. Shen, Y. Kondo, G. Rosner, L. Xiao, N.S. Hernandez, J. Vilaythong, P. Scott, S. Robert, R. Anil, J.G. Einspahr, B. Julie, D.S. Alberts, R.S. Hamilton, J. Issa, MGMT promoter methylation and field defect in sporadic colorectal cancer. JNCI 97, 1330–1338 (2005)PubMedCrossRef
40.
go back to reference X. Qian, M.A. von Wronski, T.P. Brent, Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression. Carcinogenesis 16, 1385–1390 (1995)PubMedCrossRef X. Qian, M.A. von Wronski, T.P. Brent, Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression. Carcinogenesis 16, 1385–1390 (1995)PubMedCrossRef
41.
go back to reference G.S. Watts, R.O. Pieper, J.F. Costello, Y.M. Peng, W.S. Dalton, B.W. Futscher, Methylation of discrete regions of the O6-Methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol. Cell. Biol. 17, 5612–5619 (1997)PubMedCentralPubMed G.S. Watts, R.O. Pieper, J.F. Costello, Y.M. Peng, W.S. Dalton, B.W. Futscher, Methylation of discrete regions of the O6-Methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol. Cell. Biol. 17, 5612–5619 (1997)PubMedCentralPubMed
42.
go back to reference X.C. Qian, T.P. Brent, Methylation hot spots in the 59-flanking region denote silencing of the O6-Methylguanine-DNA methyltransferase gene. Cancer Res. 57, 3672–3677 (1997)PubMed X.C. Qian, T.P. Brent, Methylation hot spots in the 59-flanking region denote silencing of the O6-Methylguanine-DNA methyltransferase gene. Cancer Res. 57, 3672–3677 (1997)PubMed
43.
go back to reference N. Takesha, B. Gerald, Sharp, N. Kenji, Hypermethylation of O6-Methylguanine-DNA Methyltransferase promoter may predict non-recurrence after chemotherapy in colorectal cancer cases. Clin. Cancer Res. 9, 5306–5312 (2003) N. Takesha, B. Gerald, Sharp, N. Kenji, Hypermethylation of O6-Methylguanine-DNA Methyltransferase promoter may predict non-recurrence after chemotherapy in colorectal cancer cases. Clin. Cancer Res. 9, 5306–5312 (2003)
44.
go back to reference R. Kumar, P. Mende, C.D. Wacker, B. Spiegelhalder, R. Preussmann, M. Siddiqi, Caffeine-derived N-nitroso compounds–I: nitrosatableprecursors from caffeine and their potential relevance in the etiology of oesophageal and gastric cancers in Kashmir, India. Carcinogenesis 13, 2179–2182 (1992)PubMedCrossRef R. Kumar, P. Mende, C.D. Wacker, B. Spiegelhalder, R. Preussmann, M. Siddiqi, Caffeine-derived N-nitroso compounds–I: nitrosatableprecursors from caffeine and their potential relevance in the etiology of oesophageal and gastric cancers in Kashmir, India. Carcinogenesis 13, 2179–2182 (1992)PubMedCrossRef
Metadata
Title
MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area
Authors
Adfar Yousuf
Mohammad Younis Bhat
Arshad A. Pandith
Dil Afroze
Nighat P. Khan
Khursheed Alam
Parveen Shah
M. Amin Shah
Syed Mudassar
Publication date
01-08-2014
Publisher
Springer Netherlands
Published in
Cellular Oncology / Issue 4/2014
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-014-0179-3

Other articles of this Issue 4/2014

Cellular Oncology 4/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine